Modern Retina Newsletter

To view this email as a web page, click here.

When and how to treat myopic traction maculopathy

Learn how peeling of the internal limiting membrane (ILM) and foveal-sparing ILM flap techniques are showing improved macular hole closure rates in difficult cases. Hiroko Terasaki, MD, shares some surgical pearls.

Novel strategies for a shifting DME paradigm

There is subset of patients with persistent DME that forms the impetus for new treatment strategies. Pravin U. Dugel, MD, outlines a list of potential candidates that may lead that paradigm shift. Who are these patients?

Continue

A new look at retinovascular features

Quantitative assessment of retinovascular features on ultra-widefield angiography showed significant improvements in leakage and ischemia following treatment with aflibercept in patients with DME and RVO. Justis P. Ehlers, MD, shares more.

Learn more

Why timing is everything in AMD

Cutters or scissors for PDR?

PFVS—New name for an old problem

The time has come for gene therapy to treat retinal disease, AMD

Suprachoroidal space: Promising route for retinal drug delivery

Meet DME thought leaders at ASRS!

Learn how doctors Nancy Holekamp and Caesar Luo incorporate ILUVIEN into their practice. RSVP at: RSVP@AlimeraSciences.com or Visit Booth 116 at ASRS to

learn about ILUVIEN.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.